Literature DB >> 25253359

Spontaneous resolution of portal vein thrombosis in cirrhosis: where do we stand, and where will we go?

Xingshun Qi, Zhiping Yang, Daiming Fan1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25253359      PMCID: PMC4196339          DOI: 10.4103/1319-3767.141680

Source DB:  PubMed          Journal:  Saudi J Gastroenterol        ISSN: 1319-3767            Impact factor:   2.485


× No keyword cloud information.
It is being gradually recognized that portal vein thrombosis (PVT) is negatively associated with the prognosis of cirrhosis.[12] But the standard treatment algorithm remains lacking.[3] Anticoagulation, which is a widely available treatment option for venous thromboembolism, is also employed for the management of PVT in cirrhotic patients.[4] Retrospective case series demonstrated a relatively low risk of anticoagulation-related bleeding and a high rate of portal vein recanalization after anticoagulation,[34] which provided the preliminary support for the use of anticoagulation in cirrhosis with PVT. However, the clinicians are very cautious of the potential bleeding secondary to anticoagulation, because cirrhosis itself has a bleeding tendency. In the dilemma of whether or not anticoagulation therapy should be employed, the investigators would rather pay more attention to the natural history of PVT in cirrhosis in the absence of any interventions. To our knowledge, spontaneous portal vein recanalization in cirrhosis has been evaluated by at least three previous case series.[567] The incidence of spontaneous recanalization varies from 30% to 50% in cirrhotic patients with PVT. In this issue of The Saudi Journal of Gastroenterology, the concept of spontaneous portal vein recanalization has been further reinforced.[8] The investigators found that partial PVT could be spontaneously recanalized or unchanged in 72.7% (16/22) of patients, and worsened in only 27.3% (6/22) of patients.[8] More importantly, in spite of a small sample size (n = 22), the study showed a significantly higher incidence of hepatic decompensation and mortality in the cirrhotic patients with worsened PVT than in those with recanalized or unchanged PVT.[8] In line with the previous studies,[5] these impressive findings suggested that anticoagulation therapy should be selectively performed in patients who would develop the thrombus extension, thereby improving survival; by contrast, it is unnecessary in those who would develop the spontaneous thrombus resolution. However, the accurate predictors of spontaneous recanalization remain poorly recognized in this study. Therefore, the behavior to stop any interventions for partial PVT in all cirrhotic patients might be radical. In accordance with previous studies,[5] the investigators also found that the severity of liver function (i.e. MELD score) was the only independent predictor for the survival and hepatic decompensation in the multivariate Cox regression analysis. In the absence of any detailed information, we fail to clearly understand whether or not the progression of PVT had been incorporated as a variable into the multivariate analysis. But it appeared to be rational that the worsened PVT and deteriorated liver function jointly increased the mortality. This consideration could be potentially supported by the accumulated evidence regarding a vicious cycle between the development of PVT and deterioration of liver function [Figure 1]. First, the portal vein flow velocity decreases with worsening liver fibrosis and liver function.[910] Subsequently, a decreased portal vein flow velocity predicts a higher risk of developing PVT.[11] portal vein flow velocity decreases with worsening liver fibrosis and liver function.[910] Subsequently, a decreased portal vein flow velocity predicts a higher risk improved liver function, thereby producing the scouring effect and spontaneously resolving the thrombus within the portal vein.[12]
Figure 1

A scheme regarding the association between the severity of liver function and development of portal vein thrombosis

A scheme regarding the association between the severity of liver function and development of portal vein thrombosis Collectively, spontaneous portal vein recanalization can be frequently observed in patients with partial PVT. This phenomenon may be attributed to the improvement of liver function. In addition, further work should focus on identifying the candidates who will develop the thrombus extension or is suitable for anticoagulation therapy.
  12 in total

1.  Anticoagulation for portal vein thrombosis in cirrhosis.

Authors:  Xingshun Qi; Guohong Han; Kaichun Wu; Daiming Fan
Journal:  Am J Med       Date:  2010-09       Impact factor: 4.965

2.  Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis.

Authors:  B V John; R Konjeti; A Aggarwal; R Lopez; A Atreja; C Miller; N N Zein; W D Carey
Journal:  Ann Hepatol       Date:  2013 Nov-Dec       Impact factor: 2.400

3.  Natural course of extrahepatic nonmalignant partial portal vein thrombosis in patients with cirrhosis.

Authors:  Angelo Luca; Settimo Caruso; Mariapina Milazzo; Gianluca Marrone; Giuseppe Mamone; Francesca Crinò; Luigi Maruzzelli; Roberto Miraglia; Gaetano Floridia; Giovanni Vizzini
Journal:  Radiology       Date:  2012-08-13       Impact factor: 11.105

4.  Occlusive portal vein thrombosis as a new marker of decompensated cirrhosis.

Authors:  Xingshun Qi; Ming Bai; Zhiping Yang; Shanshan Yuan; Cheng Zhang; Guohong Han; Daiming Fan
Journal:  Med Hypotheses       Date:  2011-01-08       Impact factor: 1.538

5.  Doppler ultrasound of hepatic blood flow for noninvasive evaluation of liver fibrosis compared with liver biopsy and transient elastography.

Authors:  H H Lutz; N Gassler; F W Tischendorf; C Trautwein; J J W Tischendorf
Journal:  Dig Dis Sci       Date:  2012-04-10       Impact factor: 3.199

6.  De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes.

Authors:  Hitoshi Maruyama; Hidehiro Okugawa; Masanori Takahashi; Osamu Yokosuka
Journal:  Am J Gastroenterol       Date:  2013-02-05       Impact factor: 10.864

7.  Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators.

Authors:  Gennaro D'Amico; Roberto De Franchis
Journal:  Hepatology       Date:  2003-09       Impact factor: 17.425

8.  Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension.

Authors:  G Zironi; S Gaiani; D Fenyves; A Rigamonti; L Bolondi; L Barbara
Journal:  J Hepatol       Date:  1992-11       Impact factor: 25.083

9.  Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension.

Authors:  I R Wanless; F Wong; L M Blendis; P Greig; E J Heathcote; G Levy
Journal:  Hepatology       Date:  1995-05       Impact factor: 17.425

10.  Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development.

Authors:  Maria Assunta Zocco; Enrico Di Stasio; Raimondo De Cristofaro; Marialuisa Novi; Maria Elena Ainora; Francesca Ponziani; Laura Riccardi; Stefano Lancellotti; Angelo Santoliquido; Roberto Flore; Maurizio Pompili; Gian Lodovico Rapaccini; Paolo Tondi; Giovanni Battista Gasbarrini; Raffaele Landolfi; Antonio Gasbarrini
Journal:  J Hepatol       Date:  2009-04-23       Impact factor: 25.083

View more
  2 in total

1.  Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.

Authors:  Shunichiro Fujiyama; Satoshi Saitoh; Yusuke Kawamura; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Yoshiyuki Suzuki; Fumitaka Suzuki; Yasuji Arase; Kenji Ikeda; Hiromitsu Kumada
Journal:  BMC Gastroenterol       Date:  2017-10-25       Impact factor: 3.067

Review 2.  Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.

Authors:  Aikaterini Mantaka; Aikaterini Augoustaki; Elias A Kouroumalis; Dimitrios N Samonakis
Journal:  Ann Gastroenterol       Date:  2018-03-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.